drugset / Trial / NCT00161902

Efficacy and Safety of Fibrin Sealant Vapor Heated Solvent/Detergent Treated (FS VH S/D) for Hemostasis in Subjects Undergoing Total Hip Replacement

NCT00161902 ↗

Phase 3 Completed Baxter Healthcare Corporation
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of the study is to monitor the safety of FS VH S/D and evaluate whether FS VH S/D is superior to standard treatment in reducing blood loss in subjects undergoing total hip replacement with cement-free hip prostheses.

Timeline

Start
2001-08
Primary completion
—
Completion
2003-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Fibrin Sealant Vapor-Heated Solvent/Detergent-treated Unknown — —

Indications

No indication recorded.